Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,127.20
(
0.47%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.21
(
-1.44%
)
Bitcoin
74,039.34
(
0.13%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 96778

Thursday, 07/28/2011 11:38:57 PM

Thursday, July 28, 2011 11:38:57 PM

Post# of 257253
2Q11 Yervoy sales were $95M—not bad for the first full quarter on the market, even after taking into account that some sales were for inventory stocking:

http://finance.yahoo.com/news/BristolMyers-Squibb-Delivers-bw-2995389373.html?x=0&.v=1

BMY says 40% of use to date is in the first line and 60% in the second line. The FDA approved Yervoy on 3/25/11.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now